There have been many studies on the use of different agents in the chemoprevention of CRC precursors (ACF, adenomas): calcium supplements [2], Cyclooxygenase-2 (COX-2) inhibitors [3], or other non-steroidal anti-inflammatory drugs (NSAIDs) [4,5]. The gene discussed is PTGS2; the disease is colorectal carcinoma.